Other cell cycle regulators, such as the DNA damage checkpoint kinases and spindle-assembly checkpoint proteins, are also being evaluated as potential new drug targets to improve cancer therapy.

This developmental transition is accompanied by cell cycle adaptation, such as lengthening or shortening of the gap phases G1 and G2. However, regulation of these cell cycle changes is poorly ...

Data retention and its statistics are the key issues for the development of next generation phase-change memory (PCM) arrays. For this reason, the understanding and modeling of cell-to-cell and ...